Company intelligence / Profile preview

CMS Medical Venture Investment

Hong Kong, China

Ownership: Private
Development stage: Other

Overview

CMS Medical Venture Investment is the Hong Kong–based corporate venture arm of China Medical System that makes minority equity investments in early-stage biotech and life science companies, often alongside regional development and commercialization agreements led by its parent company.

Industry: Investors

Partnerships

Acticor Biotech – equity investment via Series B financing, alongside a regional development and commercialization collaboration between Acticor Biotech and China Medical System/CMS Medical LimitedCan-Fite BioPharma – received payments under a regional licensing agreement in which CMS Medical Venture Investment Limited is a party to the investment componentCambridge Judge Business School and AstraZeneca – indirect collaboration through China Medical System’s UK early‑stage biotech investment initiative with a Cambridge focus

Beyond the preview

Go deeper on CMS Medical Venture Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMS Medical Venture Investment.

Explore the full profile